Ariana María
Montes Martínez
Complexo Hospitalario Universitario de Santiago
Santiago de Compostela, EspañaPublicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (12)
2019
2017
2016
-
Anti-carbamylated protein antibodies as a reproducible independent type of rheumatoid arthritis autoantibodies
PLoS ONE, Vol. 11, Núm. 8
-
Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis
Pharmacogenomics Journal, Vol. 16, Núm. 2, pp. 137-140
2015
-
Brief report: Lack of replication of an association between anti-citrullinated fibrinogen and subclinical atherosclerosis in patients with rheumatoid arthritis
Arthritis and Rheumatology, Vol. 67, Núm. 11, pp. 2861-2865
-
FCGR polymorphisms in the treatment of rheumatoid arthritis with Fc-containing TNF inhibitors
Pharmacogenomics, Vol. 16, Núm. 4, pp. 333-345
-
Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: A case-only study
Arthritis Research and Therapy, Vol. 17, Núm. 1
2014
-
Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis
Pharmacogenetics and Genomics, Vol. 24, Núm. 5, pp. 238-245
-
Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: A genome-wide association study replication and meta-analysis
Arthritis Research and Therapy, Vol. 16, Núm. 2
2013
-
Reply
Arthritis and Rheumatism
2012
-
Association of anti-citrullinated vimentin and anti-citrullinated α-enolase antibodies with subsets of rheumatoid arthritis
Arthritis and Rheumatism, Vol. 64, Núm. 10, pp. 3102-3110
2011
-
Particular association of clinical and genetic features with autoimmunity to citrullinated α-enolase in rheumatoid arthritis
Arthritis and Rheumatism, Vol. 63, Núm. 3, pp. 654-661